combined therapy

Zytiga in High Doses and Zytiga Combined with MDV3100 Increase the Length of Response Time In Men with Advanced Prostate Cancer

According to recent trials led by The Institute of Cancer Research (ICR) (UK) and The Royal Marsden (UK) combining Zytiga (abiraterone acetate) with the yet FDA unapproved investigational drug MDV3100 could increase the number of men, with advanced prostate cancer, who respond to treatment as well as the length of time they benefit. A new [...]

By Malecare|2012-05-01T18:22:09-04:00May 1st, 2012|abiraterone acetate, Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, MDV3100, On The Horizon, Research, Uncategorized, Understanding APC|3 Comments

Combined Therapy – Using Second Line Therapy (Part 5 of a Series of Posts on Second Line Hormone Therapy)

All the drugs used as 2nd line hormone therapy are only partially effective. Only some individuals respond and receive any benefit from them, but there has been some recent research into combining the drugs. At the last American Society of Clinical Oncology (ASCO), Dr. Eric Small, M.D. presented a abstract about his recent experimentation of [...]

By Malecare|2010-09-22T10:31:39-04:00September 22nd, 2010|2nd line hormone therapy, Advanced Prostate Cancer, Drugs & Treatments, General Information, Uncategorized, Understanding APC|0 Comments